PDA

View Full Version : Blood Cancers & T-Cell Therapy


Last hard class
02-18-2016, 09:33
http://www.msn.com/en-us/health/medical/new-cancer-therapy-sends-93-percent-of-incurable-patients-into-remission/ar-BBpDHEp?li=BBnb4R7

Some promising news on the cancer front.


LHC

PedOncoDoc
02-18-2016, 11:00
http://www.msn.com/en-us/health/medical/new-cancer-therapy-sends-93-percent-of-incurable-patients-into-remission/ar-BBpDHEp?li=BBnb4R7

Some promising news on the cancer front.


LHC

This was big news 3-4 years ago when first introduced by Carl June out of Penn. A few centers are trying different modifications of this therapy and we'll see which one ends up on top. I'll be hearing updates on this topic from the world leaders in about 90 minutes - the biggest BMT and cellular therapy meeting in the world starts today.

I have to assume this release was allowed because the data will be shared at the upcoming session.
;)

Red Flag 1
02-18-2016, 14:32
This was big news 3-4 years ago when first introduced by Carl June out of Penn. A few centers are trying different modifications of this therapy and we'll see which one ends up on top. I'll be hearing updates on this topic from the world leaders in about 90 minutes - the biggest BMT and cellular therapy meeting in the world starts today.

I have to assume this release was allowed because the data will be shared at the upcoming session.
;)

Read a piece on Medscape about this, just a few days ago. Like you, I'm looking to see where this will lead us.

PedOncoDoc
02-18-2016, 14:39
Read a piece on Medscape about this, just a few days ago. Like you, I'm looking to see where this will lead us.

It was a great session with a talk suggesting that CAR T-cells can be made with antibodies for multiple targets using and/or programming based upon the constructs. If so, this could blow the field wide open and make the targeting of solid tumors and non B-cell malignancies possible.

Red Flag 1
02-18-2016, 16:59
It was a great session with a talk suggesting that CAR T-cells can be made with antibodies for multiple targets using and/or programming based upon the constructs. If so, this could blow the field wide open and make the targeting of solid tumors and non B-cell malignancies possible.

We could be looking at the finding that could change Oncology.